Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)
57.90
-0.70 (-1.19%)
Jun 2, 2025, 1:30 PM CST
TPE:1720 Revenue
Standard Chemical & Pharmaceutical had revenue of 1.64B TWD in the quarter ending March 31, 2025, with 1.64% growth. This brings the company's revenue in the last twelve months to 6.82B, up 7.16% year-over-year. In the year 2024, Standard Chemical & Pharmaceutical had annual revenue of 6.79B with 8.81% growth.
Revenue (ttm)
6.82B
Revenue Growth
+7.16%
P/S Ratio
1.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.79B | 549.46M | 8.81% |
Dec 31, 2023 | 6.24B | 388.40M | 6.64% |
Dec 31, 2022 | 5.85B | 1.25B | 27.09% |
Dec 31, 2021 | 4.60B | 298.68M | 6.94% |
Dec 31, 2020 | 4.31B | 368.27M | 9.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |
Oneness Biotech | 117.33M |
Lumosa Therapeutics | 43.59M |